June 22, 2009

New Journals from the Resource Centre for September 2011
The Resource Centre is open to the public Monday to Friday 9 am to 5 pm.
Books, videos and DVDs are available for loan.
Reference materials and journals are not available for loan, but can be photocopied free of
For a complete listing of items in our collection, as well as an extensive list of
online materials in over 70 languages, please consult our online Resource Centre Catalogue


The following journal issues have been published.
Please indicate which articles you would like to view and I will email/fax them to you as
Please provide Journal title, issue number, pages & title for each article required.
Requested by: _________________________________
Email: ____________________________________ Fax: ____________________________________ Phone: ____________________________________ For more information please contact:
Marg Cameron
Information Resources Coordinator
Alzheimer Society of Toronto
20 Eglinton Avenue West,
16th floor, Toronto, Ontario M4R 1K8

Alzheimer Disease and Associated Disorders Vol. 25 no 3. July/September 2011 Abstracts available online at Diversity and Disparity in Dementia: The Impact of Ethnoracial Differences in Alzheimer Disease Geographic Distribution of Dementia Mortality: Elevated Mortality Rates for Black and White Americans by Early Onset Dementia: Characteristics in a Large Cohort From Academic Memory Clinics PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer The Efficacy of Nonpharmacological Treatment for Dementia-related Apathy Dementia=(MC)2: A 4-item Screening Test for Mild Cognitive Impairment and Dementia Functional Impairment in the Diagnosis of Mild Cognitive Impairment The Neuroanatomical Substrate of Lexical-Semantic Decline in MCI APOE ε4 Carriers and Noncarriers Cortical Thinning in Verbal, Visual, and Both Memory-predominant Mild Cognitive Impairment Differential Impact of ApoE ε4 on Cortical Activation During Famous Face Recognition in Cognitively Intact Individuals and Patients With Amnestic Mild Cognitive Impairment Emotional Memory Deficit and its Psychophysiological Correlate in Family Caregivers of Patients With Prognostic Factors for Weight Loss Over 1-year Period in Patients Recently Diagnosed With Mild Alzheimer Microcephaly Genes and Risk of Late-onset Alzheimer Disease Association Study of the GAB2 Gene With the Risk of Alzheimer Disease in the Chinese Population Alzheimer’s & Dementia: The Journal of the Alzheimer's Association Vol. 7 no 5. September 2011 Abstracts available online a Magnetic resonance imaging-measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer’s disease patients Cognitive, biochemical, and imaging profile of patients suffering from idiopathic normal pressure Frequency of Alzheimer’s disease pathology at autopsy in patients with clinical normal pressure Impact of apolipoprotein ɛ4–cerebrospinal fluid beta-amyloid interaction on hippocampal volume loss over 1 Anesthesia in presymptomatic Alzheimer’s disease: A study using the triple-transgenic mouse model Neuropsychiatric symptoms in Alzheimer’s disease Dementia and Alzheimer’s disease: A new direction. The 2010 Jay L. Foster Memorial Lecture Dementia and Geriatric Cognitive Disorders Vol. 32 no 1. September 2011 Abstracts available online at 1-10 A Multicenter Brain Perfusion SPECT Study Evaluating Idiopathic Normal-Pressure Hydrocephalus on 11- Decision-Making in Frontotemporal Dementia: Clinical, Theoretical and Legal Implications 17 18- A Review of Transcranial Magnetic Stimulation in the in vivo Functional Evaluation of Central 25 26- Paraoxonase 1 Gene Polymorphisms Do Not Influence the Response to Treatment in Alzheimer’s 31 32- Subtypes of Dementia: A Study from a Memory Clinic in India 38 39- Evaluating the Quality of Life of People with Dementia in Residential Care Facilities 44 45- Clinical Course of Patients with Familial Early-Onset Alzheimer’s Disease Potential y Lacking Senile 54 Plaques Bearing the E693Δ Mutation in Amyloid Precursor Protein 55- A Blood-Based Algorithm for the Detection of Alzheimer’s Disease 62 63- Influence of Variation in the Follicle-Stimulating Hormone Receptor Gene (FSHR) and Age at 69 Menopause on the Development of Alzheimer’s Disease in Women 70- Decrease of GABAergic Markers and Arc Protein Expression in the Frontal Cortex by Intraventricular 78 JAD: Journal of Alzheimer’s Disease Vol. 26 no 2. 2011 Abstracts available online a TNF and Leptin Tell Essentially the Same Story in Alzheimer’s Disease Hippocampal Volume Differences Between Healthy Young Apolipoprotein E ε2 and ε4 Carriers Cessation versus Continuation of Galantamine Treatment after 12 Months of Therapy in Patients with Alzheimer’s Disease: A Randomized, Double Blind, Placebo Controlled Withdrawal Trial Screening for Alzheimer's Disease Among Illiterate Elderly: Accuracy Analysis for Multiple Use of Antiepileptic Drugs Among Community-Dwel ing Persons with Alzheimer’s Disease in The Impact of a Novel Apolipoprotein E and Amyloid-β Protein Precursor-Interacting Protein on the Long-Term Stability of Alzheimer’s Disease Biomarker Proteins in Cerebrospinal Fluid Tryptamine-Induced Tryptophanyl-tRNAtrp Deficiency in Neurodifferentiation and Neurodegeneration Interplay: Progenitor Activation with Neurite Growth Terminated in Alzheimer’s Disease Neuronal Vesicularization and Fragmentation Long-Term Overexpression of Heme Oxygenase 1 Promotes Tau Aggregation in Mouse Brain by JNK Plays a Key Role in Tau Hyperphosphorylation in Alzheimer’s Disease Models Resting State Cortical Electroencephalographic Rhythms and White Matter Vascular Lesions in Subjects with Alzheimer’s Disease: An Italian Multicenter Study Swallowing Intentional Off-State in Aging and Alzheimer’s Disease: Preliminary Study Potentiation of Tau Aggregation by cdk5 and GSK3β Meta-Analysis of Plasma Amyloid-βlevels in Alzheimer’s Disease APOE and AβPP Gene Variation in Cortical and Cerebrovascular Amyloid-β Pathology and Alzheimer’s Disease: A Population-Based Analysis The Cysteine Protease Inhibitor, E64d, Reduces Brain Amyloid-β and Improves Memory Deficits in Alzheimer’s Disease Animal Models by Inhibiting Cathepsin B, but not BACE1, β-Secretase Activity JAD: Journal of Alzheimer’s Disease Vol. 26 no 1. 2011 Abstracts available online a Uncertain Progress on the Fuzzy Boundaries of Alzheimer’s Disease: Reading Between the Vitamin C Restores Behavioral Deficits and Amyloid-β Oligomerization without Affecting Plaque Formation in a Mouse Model of Alzheimer’s Disease A Novel MAPT Mutation Associated with the Clinical Phenotype of Progressive Nonfluent Aphasia Depression History, Depressive Symptoms, and Incident Dementia: The 3C Study Stem Cell Factor Plasma Levels are Decreased in Alzheimer’s Disease Patients with Fast Cognitive Decline after One-Year Follow-Up Period: The Pythia-Study Possible Retrogenesis Observed with Fiber Tracking: An Anteroposterior Pattern of White Matter Disintegrity in Normal Aging and Alzheimer’s Disease Peripheral Oxidative Stress Biomarkers in Mild Cognitive Impairment and Alzheimer’s Disease The Role of CNI-1493 in the Function of Primary Microglia with respect to Amyloid-β Selenium and Alzheimer’s Disease: A Meta-Analysis Which Memory Task for My Mouse? A Systematic Review of Spatial Memory Performance in the 127- Interaction Between Vascular Factors and the APOE E4 Allele in Predicting Rate of Progression in 134 135- Amyloid-β42 is Associated with Cognitive Impairment in Healthy Elderly and Subjective Cognitive 142 143- Cholinesterase Inhibitors Improve both Memory and Complex Learning in Aged Beagle Dogs 155 Face Short-Term Memory-Related Electroencephalographic Patterns can Differentiate Multi- versus Single-Domain Amnestic Mild Cognitive Impairment 171- Autoantibodies Against Amyloid and Glial-Derived Antigens are Increased in Serum and 179 Cerebrospinal Fluid of Lewy Body-Associated Dementias 181- CSF Tau Levels Influence Cortical Plasticity in Alzheimer’s Disease Patients 186 187- Sodium Butyrate Improves Memory Function in an Alzheimer’s Disease Mouse Model When 197 Administered at an Advanced Stage of Disease Progression Journal of Geriatric Psychiatry and Neurology Vol. 24 #3 September 2011 Abstracts available online a 123- Pittsburgh Compound B-Negative Dementia—A Possibility of Misdiagnosis of Patients With Non-126 Alzheimer Disease-Type Dementia as Having AD Cerebral Metabolism, Cognition, and Functional Abilities in Alzheimer Disease Increasing Depressive Symptoms in Children of Alzheimer Parents The Impact of Depression on Dual Tasking Among Patients With High Fall Risk 151- Midlife Motivational Abilities Predict Apathy and Depression in Alzheimer Disease: The Aging, 160 Anemia Associated With Depressive Symptoms in Mild Cognitive Impairment With Severe White The IQCODE Versus a Single-Item Informant Measure to Discriminate Between Cognitively Intact Individuals and Individuals With Dementia or Cognitive Impairment

Source: http://www.dementiatoronto.org/news/NewMaterials/2011Sept_NewJournals.pdf


MEDICAL MARIJUANA Those currently suffering from debilitating conditions unrelieved by legally available drugs, and who might find relief with marijuana, will find little comfort in a promise of a better drug 10 years from now. In terms of good medicine, marijuana should rarely be recommended unless all reasonable options have been eliminated. But then what? It is conceivable that the medica


Case Studies in Pain Management: Complex Regional Pain Complex Regional Pain Patient history Treatment plan provided dramatic pain relief. This permit-The last thing this 55-year-old female real-ted the patient to tolerate well the occu-to provide this patient desperately needed pational therapy of her hand; it took only carpal tunnel-release surgery was a seri-respite from

© 2010-2017 Pharmacy Pills Pdf